Financials
- Market Capitalization 45.73 M
- Employee 115
- Founded 1998
- CEO N/A
- Website www.celularity.com
- Headquarter Delaware, United States
- FIGI BBG00P2RTT34
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4259 | MCRB Seres Therapeutics, Inc. - Common Stock | 5.11 USD | +3.23% | +13.30% | +7.13% | -37.91% | 50.80 M USD | ||
| 4281 | TCRX TScan Therapeutics, Inc. - Common Stock | 0.75 USD | 0.00% | -5.06% | -1.32% | -58.33% | 47.63 M USD | ||
| 4292 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.94 USD | -3.09% | +10.59% | +108.89% | -27.69% | 45.68 M USD | ||
| 4295 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.19 USD | -1.65% | -4.80% | -0.83% | -17.36% | 44.95 M USD |
Frequently asked questions about Celularity Inc. Class A Common Stock
What is the Celularity Inc. Class A Common Stock stock price today?
The current price of Celularity Inc. Class A Common Stock (CELU) is 1.58. Over the past 24 hours, the stock has changed by -24.76%. Follow the CELU chart for real-time price dynamics.
What is the stock ticker of Celularity Inc. Class A Common Stock?
Celularity Inc. Class A Common Stock trades under the ticker CELU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Celularity Inc. Class A Common Stock stock going up?
CELU has changed by +105.19% over the last week, +132.35% over the last month, and -49.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Celularity Inc. Class A Common Stock?
Celularity Inc. Class A Common Stock currently has a market capitalization of 45.73 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Celularity Inc. Class A Common Stock earnings last quarter?
Last quarter, Celularity Inc. Class A Common Stock reported earnings of -0.85 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Celularity Inc. Class A Common Stock revenue for the last quarter?
Celularity Inc. Class A Common Stock reported quarterly revenue of 4.1 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Celularity Inc. Class A Common Stock net income for the last quarter?
Celularity Inc. Class A Common Stock reported net income of -24.36 M for the last quarter. The previous quarter showed -23.08 M, which means net income changed by -5.57%.
How many employees does Celularity Inc. Class A Common Stock have?
As of the latest available data, Celularity Inc. Class A Common Stock has 115 employees. Workforce size can provide additional context about the company's scale and operations.
What is Celularity Inc. Class A Common Stock EBITDA?
Celularity Inc. Class A Common Stock EBITDA is -23.25 M, and its EBITDA margin is -566.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Celularity Inc. Class A Common Stock stock?
You can buy Celularity Inc. Class A Common Stock (CELU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Celularity Inc. Class A Common Stock stock?
Investing in Celularity Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CELU chart and related analysis on metatrader.com as part of your research.